83 related articles for article (PubMed ID: 741967)
1. [The functioning of the fibrinolytic system in Behçet's syndrome].
Asbeck F; Meyer-Boernecke D; van de Loo J
Verh Dtsch Ges Inn Med; 1978; (84):1359-62. PubMed ID: 741967
[No Abstract] [Full Text] [Related]
2. Decreased fibrinolysis in Behçet's disease.
Chajek T; Aronowski E; Izak G
Thromb Diath Haemorrh; 1973 Jun; 29(3):610-8. PubMed ID: 4761829
[No Abstract] [Full Text] [Related]
3. [Blood coagulation and fibrinolytic system in Behçet's disease (author's transl)].
Hamada T; Hosoi Y; Yoshimura R; Yamamoto S
Nihon Hifuka Gakkai Zasshi; 1978 Sep; 88(10):615-25. PubMed ID: 309522
[No Abstract] [Full Text] [Related]
4. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
Kagawa H; Okubo S
Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
[TBL] [Abstract][Full Text] [Related]
5. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
[TBL] [Abstract][Full Text] [Related]
6. [Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].
Conard J; Horellou MH; Wechsler B; Fassin D; Bletry O; Godeau P; Samama M
J Mal Vasc; 1988; 13(3):257-61. PubMed ID: 3171405
[TBL] [Abstract][Full Text] [Related]
7. Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.
Stathakis NE; Economopoulos TC; Papayannis AG; Thomopoulos D
Blut; 1977 Mar; 34(3):215-22. PubMed ID: 843627
[TBL] [Abstract][Full Text] [Related]
8. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
9. Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease.
Kluft C; Michiels JJ; Wijngaards G
Scand J Haematol; 1980 Nov; 25(5):423-30. PubMed ID: 6452679
[TBL] [Abstract][Full Text] [Related]
10. Current concepts of Behçet's disease.
Collum LM; Mullaney J; Bowell R
Trans Ophthalmol Soc U K (1962); 1981; 101 (Pt 4)():422-8. PubMed ID: 6964263
[TBL] [Abstract][Full Text] [Related]
11. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidaemia in Behcet's disease as a thrombotic risk factor.
Ricart JM; Vayá A; Santaolaria M; España F; Aznar J
Ann Rheum Dis; 2006 Sep; 65(9):1248-9. PubMed ID: 16905584
[No Abstract] [Full Text] [Related]
13. [Parameters of hemostasis in Behçet's disease].
Dupuy E; Tobelem G; Bourgeois P; Soria C; Pellerin A; Bellucci S; Caen JP
Rev Med Interne; 1983 Dec; 4(4):317-21. PubMed ID: 6665348
[TBL] [Abstract][Full Text] [Related]
14. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state.
Ozatli D; Sayinalp N; Büyükaşik Y; Karakuş S; Haznedaroglu IC; Kirazli S; Ozcebe O; Dündar SV
Rheumatol Int; 2002 Jan; 21(4):137-40. PubMed ID: 11843168
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis.
Ricart JM; Ramón LA; Vayá A; España F; Santaolaria ML; Todolí J; Castelló R; Fontcuberta J; Estellés A
Br J Haematol; 2008 May; 141(5):716-9. PubMed ID: 18341631
[TBL] [Abstract][Full Text] [Related]
16. [Studies on fibrinolytic activity in Behçet's disease. 3. An approach by affinity chromatography (author's transl)].
Saito K
Nippon Ganka Gakkai Zasshi; 1973 Sep; 77(9):1443-51. PubMed ID: 4271707
[No Abstract] [Full Text] [Related]
17. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
Menon IS
Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
[No Abstract] [Full Text] [Related]
18. Decreased fibrinolytic activity in Behçet's syndrome.
Sousa Pinto J; Nunes VJ
Acta Med Port; 1983; 4(7-8):339-41. PubMed ID: 6637585
[No Abstract] [Full Text] [Related]
19. Budd-Chiari syndrome: a common complication of Behçet's disease.
Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
[TBL] [Abstract][Full Text] [Related]
20. Right atrial and ventricular thrombi in Behçet's disease: a case report and review of literature.
Gürgün C; Sagcan A; Cinar CS; Yagdi T; Zoghi M; Tekten T; Kultursay H
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):107-10. PubMed ID: 10691105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
